Neuland Laboratories Limited (NEULANDLAB)

13,437.95

INR
-400.80(-2.90%)
As of December 26, 2024 9:59:00 AM

Valuation Metrics

Market Cap
₹17824.29 Cr
Enterprise Value
₹17740.33 Cr
P/E Ratio (TTM)
63.76
Forward P/E
36.53
PEG Ratio
NA
Price to Sales (TTM)
11.66

Financial Metrics

Gross Margin
48.61%
Operating Margin
14.85%
Return on Equity
22.13%
Revenue (TTM)
₹1528.28 Cr-25.6%
EBITDA
₹427.44 Cr
EPS (TTM)
₹217.87-63.2%

Balance Sheet

Total Cash
₹190.36 Cr
Total Debt
₹109.49 Cr
Debt to Equity
7.85%

Stock Information

52 Week Range
₹5021.1 - ₹18100
Beta
0.98
Shares Outstanding
₹1.28 Cr

Dividends & Splits

Forward Dividend Yield
0.42%
Trailing Dividend Yield
NA
Payout Ratio
6.42%

Neuland Laboratories Limited (NEULANDLAB)

13,437.95

INR
-400.80(-2.90%)
As of December 26, 2024 9:59:00 AM

Valuation Metrics

Market Cap
₹17824.29 Cr
Enterprise Value
₹17740.33 Cr
P/E Ratio (TTM)
63.76
Forward P/E
36.53
PEG Ratio
NA
Price to Sales (TTM)
11.66

Financial Metrics

Gross Margin
48.61%
Operating Margin
14.85%
Return on Equity
22.13%
Revenue (TTM)
₹1528.28 Cr-25.6%
EBITDA
₹427.44 Cr
EPS (TTM)
₹217.87-63.2%

Balance Sheet

Total Cash
₹190.36 Cr
Total Debt
₹109.49 Cr
Debt to Equity
7.85%

Stock Information

52 Week Range
₹5021.1 - ₹18100
Beta
0.98
Shares Outstanding
₹1.28 Cr

Dividends & Splits

Forward Dividend Yield
0.42%
Trailing Dividend Yield
NA
Payout Ratio
6.42%